Accueil・Liste d'Actions・Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Fermé

25.51 2.37

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

24.63

Max

24.92

Chiffres clés
By Trading Economics
Revenu	-20M -40M
Ventes	-9.3M 62M
BPA	-0.1
Marge bénéficiaire	-64.64
Employés	624
EBITDA	-19M -34M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+0.56% upside

Dividendes
By Acuity
Prochains Résultats	4 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	68M 3.7B
Ouverture précédente	23.14
Clôture précédente	25.51

Adaptive Biotechnologies Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 août 2026, 23:52 UTC

Correlated Moves

The US 30Y Treasury Bond Index is trading lower, reaching its lowest point in a month amid cautious market sentiment and correlated asset declines.

9 août 2026, 23:51 UTC

Bitcoin and Ethereum decline amid bearish sentiment, while U.S. labor data sparks record highs in equity markets and lowers Fed rate hike expectations.

9 août 2026, 23:51 UTC

Singapore's markets closed for National Day; Japan's BOJ releases opinions, while China's inflation and PPI growth fall short of expectations, raising economic stability concerns.

9 août 2026, 23:51 UTC

U.S. equity markets rally as disappointing July jobs data lowers Fed rate hike expectations, while Bitcoin and Ethereum decline amid cautious investor sentiment.

9 août 2026, 23:51 UTC

Singapore's markets closed for National Day; Japan's monetary policy remains unclear while China's inflation drops to 0.5%, raising deflation concerns.

9 août 2026, 23:51 UTC

Retail Sales Ex Autos Expected to Rise 0.2% in July Amid Mixed Economic Signals

9 août 2026, 23:51 UTC

Japan's Q2 2026 GDP Growth Rate Release Expected at 0.5% Amid Mixed Market Sentiment and Geopolitical Concerns

9 août 2026, 23:51 UTC

Japan's GDP Growth Forecasted at 0.02% for Q2 Amid Mixed Economic Sentiment and Global Uncertainties

9 août 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading lower during the session, reflecting cautious market sentiment amid slight declines in Ethereum and minimal hedge fund re-grossing in AI themes.

9 août 2026, 23:41 UTC

BoJ Summary of Opinions Release Expected to Clarify Interest Rate Outlook Amidst Mixed Market Sentiment and Global Economic Trends.

9 août 2026, 23:41 UTC

Japan's June current account data expected to show a significant surplus decline, raising concerns about economic challenges and impacting financial markets.

9 août 2026, 23:41 UTC

U.S. Retail Sales Expected to Rise 0.1% in August Amid Cautious Consumer Sentiment and Economic Uncertainty

9 août 2026, 23:31 UTC

Market Awaits July 2026 PPI Release Amid Mixed Inflation Signals and Potential Deflationary Pressures.

9 août 2026, 23:31 UTC

Correlated Moves

Cardano is declining in today's session, continuing a downward trend observed since Saturday. The asset's movement reflects broader bearish sentiment in the market.

9 août 2026, 23:21 UTC

Core Producer Prices Expected to Rise 0.2% Amid Slower Inflation and Cautious Investor Sentiment Ahead of August Release

9 août 2026, 23:01 UTC

Palladium is trading lower during Sunday’s session, despite earlier gains. The asset remains above its 20-day moving average and near a one-month high.

9 août 2026, 23:01 UTC

Silver has been gaining since Friday's close, currently above its 20-day moving average. The asset reached a session high before pulling back slightly.

9 août 2026, 23:01 UTC

Silver/CAD is trading higher since Friday's close, reflecting a cumulative return of 0.17%. The price remains above its 20-day moving average.

9 août 2026, 23:01 UTC

Gold/SGD is trading roughly flat, remaining above its 20-day moving average and near the upper end of its one-month range.

9 août 2026, 23:01 UTC

Correlated Moves

Gold/NZD is trading higher, reflecting volatility earlier in the session. The asset remains above its 20-day moving average and near its one-month range's upper end.

9 août 2026, 23:01 UTC

The US 2Y Treasury Bond Index is trading higher, remaining steady near the upper end of its one-month trading range. No specific news was identified.

9 août 2026, 23:01 UTC

Correlated Moves

Gold/JPY is advancing, reflecting a positive trend since Friday's close. The asset remains above its 20-day moving average and near its one-month range high.

9 août 2026, 23:01 UTC

Gold and silver are trading lower, continuing a downward trend since Friday's close. The assets briefly rebounded earlier in the session.

9 août 2026, 23:01 UTC

Correlated Moves

Gold/GBP is trading roughly flat, influenced by a slight increase in Silver. Market sentiment remains cautious amid minimal hedge fund re-grossing within AI themes.

9 août 2026, 23:01 UTC

Silver/NZD is higher today, maintaining a position above its 20-day moving average after pulling back from earlier session highs. No specific news was identified.

9 août 2026, 23:01 UTC

Silver/JPY is trading higher today, maintaining a position above its 20-day moving average. The asset showed fluctuations earlier in the session.

9 août 2026, 23:01 UTC

Silver/HKD is higher during Sunday’s session, continuing its positive momentum from Friday. The asset remains above its 20-day moving average.

9 août 2026, 23:01 UTC

Correlated Moves

Gold/CHF is trading roughly flat, maintaining stability after a slight increase in correlation with silver amid cautious market sentiment and hedge fund activity.

9 août 2026, 23:01 UTC

Silver/SGD is advancing during the ongoing session, remaining above its 20-day moving average and near the upper end of its one-month range.

9 août 2026, 23:01 UTC

Gold/HKD is trading roughly flat, remaining 6.16% above its 20-day moving average and near the upper end of its one-month range.

Comparaison

Variation de prix

Adaptive Biotechnologies Corp prévision

Objectif de Prix

By TipRanks

0.56% hausse

Prévisions sur 12 Mois

Moyen 25.07 USD 0.56%

Haut 28 USD

Bas 21 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.